Cargando…

Natural Killer Cell Therapy: A New Treatment Paradigm for Solid Tumors

In treatments of solid tumors, adoptive transfer of ex vivo expanded natural killer (NK) cells has dawned as a new paradigm. Compared with cytotoxic T lymphocytes, NK cells take a unique position targeting tumor cells that evade the host immune surveillance by down-regulating self-antigen presentati...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Sooyeon, Lee, Joo-Ho, Kwack, KyuBum, Choi, Sang-Woon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6826624/ https://www.ncbi.nlm.nih.gov/pubmed/31614472 http://dx.doi.org/10.3390/cancers11101534

Ejemplares similares

Vitamin D and Exercise Are Major Determinants of Natural Killer Cell Activity, Which Is Age- and Gender-Specific
por: Oh, Sooyeon, et al.
Publicado: (2021)

Downregulation of LOC441461 Promotes Cell Growth and Motility in Human Gastric Cancer
por: Lee, Sang-soo, et al.
Publicado: (2022)

Role of Nuclear-Receptor-Related 1 in the Synergistic Neuroprotective Effect of Umbilical Cord Blood and Erythropoietin Combination Therapy in Hypoxic Ischemic Encephalopathy
por: Choi, Joo-Wan, et al.
Publicado: (2022)

Pilot Study of a Next-Generation Sequencing-Based Targeted Anticancer Therapy in Refractory Solid Tumors at a Korean Institution
por: Park, Hyung Soon, et al.
Publicado: (2016)

Interaction between thyroglobulin and ADAMTS16 in premature ovarian failure
por: Pyun, Jung-A, et al.
Publicado: (2014)

Nitric oxide synthase Type II expression by different cell types in MHV-JHM encephalitis suggests distinct roles for nitric oxide in acute versus persistent virus infection
por: Grzybicki, Dana M, et al.
Publicado: (1997)

Sex-specific differences in the association of a common aldehyde dehydrogenase 2 gene polymorphism and alcohol consumption with stroke risk in a Korean population: a prospective cohort study
por: Shin, Chol, et al.
Publicado: (2015)

Therapeutic Potential and Challenges of Natural Killer Cells in Treatment of Solid Tumors
por: Gras Navarro, Andrea, et al.
Publicado: (2015)

Treatment of solid tumor with autologous natural killer cells in mouse models
por: Liao, Nan-Shih
Publicado: (2014)

Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
por: Nayyar, Gaurav, et al.
Publicado: (2019)

Photoimmunotherapy: A New Paradigm in Solid Tumor Immunotherapy
por: Peng, Zheng, et al.
Publicado: (2022)

Sonazoid-Conjugated Natural Killer Cells for Tumor Therapy and Real-Time Visualization by Ultrasound Imaging
por: Song, Hyeong-Woo, et al.
Publicado: (2021)

CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas
por: Ahn, Ju Won, et al.
Publicado: (2020)

Targeting Natural Killer T Cells in Solid Malignancies
por: Ingram, Zewde, et al.
Publicado: (2021)

Strategies to Augment Natural Killer (NK) Cell Activity against Solid Tumors
por: Chen, Ziqing, et al.
Publicado: (2019)

Approaches to Enhance Natural Killer Cell-Based Immunotherapy for Pediatric Solid Tumors
por: Quamine, Aicha E., et al.
Publicado: (2021)

Patient’s Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers
por: Messaoudene, Meriem, et al.
Publicado: (2017)

Correction: Ahn, J.W., et al. CeRNA Network Analysis Representing Characteristics of Different Tumor Environments Based on 1p/19q Codeletion in Oligodendrogliomas. Cancers 2020, 12, 2543
por: Ahn, Ju Won, et al.
Publicado: (2021)

Functional Validation of Rare Human Genetic Variants Involved in Homologous Recombination Using Saccharomyces cerevisiae
por: Lee, Min-Soo, et al.
Publicado: (2015)

Screening study for genetic polymorphisms affecting pharmacokinetics of talniflumate
por: Jin, Li Hua, et al.
Publicado: (2017)

A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells
por: Tallerico, Rossana, et al.
Publicado: (2016)

Role of RGMc as a Neogenin Ligand in Follicular Development in the Ovary
por: Kim, Yu Jin, et al.
Publicado: (2021)

Novel Application of Radotinib for the Treatment of Solid Tumors via Natural Killer Cell Activation
por: Kim, Kyung Eun, et al.
Publicado: (2018)

Intraocular Involvement of a Nasal Natural Killer T-Cell Lymphoma: A Case Report
por: Yoo, Jae Ho, et al.
Publicado: (2012)

Comparative clinical benefits of systemic adjuvant therapy for paradigm solid tumors
por: Kirkwood, John M., et al.
Publicado: (2012)

Evaluation of tumor response to cytokine-induced killer cells therapy in malignant solid tumors
por: Li, Xiao-Dong, et al.
Publicado: (2014)

Diplotyper: diplotype-based association analysis
por: Kim, Sunshin, et al.
Publicado: (2013)

Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors
por: Chambers, Andrea M., et al.
Publicado: (2019)

Chimeric antigen receptor-natural killer cells: Novel insight into immunotherapy for solid tumors (Review)
por: Peng, Xiaobo, et al.
Publicado: (2021)

Engineered natural killer cells impede the immunometabolic CD73-adenosine axis in solid tumors
por: Chambers, Andrea M, et al.
Publicado: (2022)

Targeting immune checkpoints: how to use natural killer cells for fighting against solid tumors
por: Ghaedrahmati, Farhoodeh, et al.
Publicado: (2022)

Prognostic Significance of Tumor-Infiltrating Natural Killer Cells in Solid Tumors: A Systematic Review and Meta-Analysis
por: Zhang, Shuo, et al.
Publicado: (2020)

Delivery of human natural killer cell-derived exosomes for liver cancer therapy: an in vivo study in subcutaneous and orthotopic animal models
por: Kim, Ho Yong, et al.
Publicado: (2022)

Natural killer cells in tumor immunotherapy
por: Wang, Dongyao, et al.
Publicado: (2023)

Defective Response of Natural Killer Activity to Thyroxine in Graves’ Disease
por: Lee, Myung-Shik, et al.
Publicado: (1990)

Understanding of molecular mechanisms in natural killer cell therapy
por: Yoon, Suk Ran, et al.
Publicado: (2015)

Autologous adoptive immune-cell therapy elicited a durable response with enhanced immune reaction signatures in patients with recurrent glioblastoma: An open label, phase I/IIa trial
por: Lim, Jaejoon, et al.
Publicado: (2021)

Natural killer cells and cytotoxic T lymphocytes are required to clear solid tumor in a patient-derived xenograft
por: Le, Duy Tri, et al.
Publicado: (2021)

Natural killer cell-based therapies
por: Romagné, François, et al.
Publicado: (2011)

Allogeneic natural killer cell therapy
por: Berrien-Elliott, Melissa M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rlddh7oun9uhe3anje2b8m486b